Microbix Blog Microbix Assisting EMQN with Novel Genetic-Test EQA Program
announces the initiation of a Normal Course Issuer Bid (“NCIB”) program for the repurchase and cancellation of outstanding common shares. The post Microbix Assisting EMQN with Novel Genetic-Test EQA Program first appeared on Microbix.
Read full article »
Microbix is a Canada-based biotechnology company that develops and commercializes antigens for the treatment of infectious diseases.
Read more